Literature DB >> 8441146

Apparent cure of rheumatoid arthritis by bone marrow transplantation.

R M Lowenthal1, M L Cohen, K Atkinson, J C Biggs.   

Abstract

We describe the induction of sustained remissions and possible cure of severe erosive rheumatoid arthritis (RA) by bone marrow transplantation (BMT) in 2 patients. BMT was used to treat severe aplastic anemia which was caused by gold in one case and D-penicillamine in the other. In the 8 and 6 years since the transplants (representing 8 and 4 years since cessation of all immunosuppressive therapy, respectively), the RA in each case has been completely quiescent. Although short term remission of severe RA following BMT has been reported, these are the first cases for which prolonged followup has been available. This experience raises the question of the role of BMT itself as a therapeutic option for patients with uncontrolled destructive synovitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8441146

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  17 in total

Review 1.  Does hemopoietic stem cell transplantation have a role in treatment of severe rheumatoid arthritis?

Authors:  R M Lowenthal; S R Graham
Journal:  J Clin Immunol       Date:  2000-01       Impact factor: 8.317

2.  Antithymocyte globulin in the treatment of D-penicillamine-induced aplastic anemia.

Authors:  Haruki Kondo; Kanae Narita
Journal:  Int J Hematol       Date:  2002-05       Impact factor: 2.490

3.  Bone marrow cells are a source of undifferentiated cells to prevent Sjögren's syndrome and to preserve salivary glands function in the non-obese diabetic mice.

Authors:  Saeed Khalili; Younan Liu; Yoshinori Sumita; Ola M Maria; David Blank; Sharon Key; Eva Mezey; Simon D Tran
Journal:  Int J Biochem Cell Biol       Date:  2010-08-21       Impact factor: 5.085

Review 4.  Optimisation of cyclophosphamide therapy in systemic vasculitis.

Authors:  R Richmond; T W McMillan; R A Luqmani
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

5.  Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases.

Authors:  A Tyndall; A Gratwohl
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

6.  Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease.

Authors:  M Tamm; A Gratwohl; A Tichelli; A P Perruchoud; A Tyndall
Journal:  Ann Rheum Dis       Date:  1996-10       Impact factor: 19.103

7.  BST-1, a surface molecule of bone marrow stromal cell lines that facilitates pre-B-cell growth.

Authors:  T Kaisho; J Ishikawa; K Oritani; J Inazawa; H Tomizawa; O Muraoka; T Ochi; T Hirano
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

8.  Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT).

Authors:  D M Karussis; U Vourka-Karussis; D Lehmann; O Abramsky; A Ben-Nun; S Slavin
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

Review 9.  Cyclophosphamide and cancer: golden anniversary.

Authors:  Ashkan Emadi; Richard J Jones; Robert A Brodsky
Journal:  Nat Rev Clin Oncol       Date:  2009-09-29       Impact factor: 66.675

Review 10.  Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls.

Authors:  Natalie E Duran; Daniel W Hommes
Journal:  Therap Adv Gastroenterol       Date:  2016-04-25       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.